ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and breastfeeding is a difficult decision for women suffering from the condition. Little data exists about how long-term exposure to these medications could affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus do not develop neurological disorders like hearing loss or impaired vision seizures, febrile seizures or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication must consider the benefits of taking it versus the dangers for the fetus. The doctors don't have the information to make unambiguous recommendations however they can provide information on the risks and benefits to aid pregnant women in making an informed decision.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during their early pregnancy did not face a significantly higher risk of fetal cardiac malformations or major structural birth defects. Researchers used a large population-based study of case control to examine the prevalence of structural defects that were major in infants born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure accurate classification of the cases and to reduce the possibility of bias.

However, the researchers' study was not without its flaws. The researchers were not able, in the first place, to separate the effects triggered by the medication from the disorder. This limitation makes it difficult to determine whether the small associations observed in the exposed groups are due to the use of medication or comorbidities that cause confusion. Additionally the researchers did not examine long-term offspring outcomes.

The study found that infants whose mothers took ADHD medication during pregnancy had a higher risk of admission to the neonatal care unit (NICU), compared to those whose mothers did not take any medication during pregnancy, or had quit taking the medication prior to or during pregnancy. This increase was due to central nervous system-related disorders, and the increased risk for admission was not found to be influenced by the stimulant medications were used during pregnancy.

Women who took stimulant ADHD medication during pregnancy were also at an increased chance of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases didn't appear to be affected by the type of medication that was used during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during early pregnancy could be offset by the greater benefits to both mother and child of continued treatment for the woman's disorder. Physicians should talk to their patients about this issue and as much as possible, assist them improve coping skills which may reduce the impact of her disorder in her daily life and relationships.

Medication Interactions

Doctors are increasingly faced with the decision of whether to keep treatment or stop it during pregnancy as more women are diagnosed with ADHD. Often, these decisions are made in the absence of any evidence that is clear and definitive regardless, so doctors must weigh their knowledge about their experiences, the experiences of other doctors, and what research suggests about the subject and their own best judgment for each patient.

The issue of potential risks to infants is particularly tricky. Many of the studies on this issue are based on observational data instead of controlled research and their findings are often contradictory. The majority of studies focus on live-births, which could underestimate the severity of teratogenic effects which can cause terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these issues, by examining both data on live and deceased births.

The conclusion is that while some studies have found an association between ADHD medications and the risk of certain birth defects, other studies have found no such relationship and the majority of studies have a neutral or slightly negative effect. As a result an accurate risk-benefit analysis is required in every case.

For a lot of women with ADHD who suffer from ADHD, the decision to stop medication is difficult, if not impossible. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. A decrease in medication could also impact the ability to drive safely and complete work-related tasks, which are essential aspects of everyday life for those with ADHD.

She suggests that women who are not sure whether to take the medication or stop due to pregnancy educate family members, coworkers, and acquaintances about the condition, the impact on daily functioning and the benefits of continuing the current treatment plan. It can also help women feel more confident in her decision. It is important to note that some medications can pass through the placenta so if the patient decides to stop her ADHD medication during pregnancy and breastfeeding, she must be aware of the possibility that traces of the drug can be passed on to the baby.

Risk of Birth Defects

As the use of ADHD medication to treat the symptoms of attention deficit hyperactivity disorder (ADHD) grows as do concerns about the effects that the drugs could have on fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge about this subject. With two massive data sets, researchers were able to analyze more than 4.3 million pregnancies and see whether the use of stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, the first trimester Strongest Adhd Medication (Http://Rvolchansk.Ru) exposure to medication was associated with slightly higher risk of specific heart defects such as ventriculoseptal defect.

The researchers of the study didn't discover any link between early use of medication and other congenital anomalies, like facial deformities or club feet. The results are in the same vein as previous studies which showed an insignificant, but small increase in cardiac malformations for women who began taking ADHD medication before pregnancy. The risk grew during the latter part of pregnancy, when many women begin to discontinue their ADHD medications.

Women who took ADHD medication in the first trimester of their pregnancies were also more likely to experience caesarean section, low Apgar score following delivery, and a baby that required breathing assistance during birth. However the authors of the study were not able to eliminate bias due to selection by restricting the study to women who did not have any other medical conditions that could be a contributing factor to these findings.

Researchers hope that their research will provide doctors with information when they encounter pregnant women. They advise that while discussing risks and benefits is important, the decision to stop or continue medication should be based on the woman's needs and the severity of her ADHD symptoms.

The authors caution that, even though stopping the medication is a possibility to look into, it is not advised due to the high rate depression and other mental disorders for women who are pregnant or have recently given birth. Additionally, the research suggests that women who choose to stop their medications are more likely to experience a difficult time adjusting to life without them after the baby's arrival.

Nursing

It can be a stressful experience becoming a mother. Women who suffer from ADHD who must work through their symptoms while attending doctor appointments as well as getting ready for the arrival of their child and adapting to new routines in the home are often faced with a number of difficulties. As such, many women decide to continue taking their ADHD medications throughout pregnancy.

The risk for breastfeeding infant is not too high since the majority of stimulant medications passes through breast milk at a low level. However, the frequency of exposure to medications by the newborn can vary depending on the dosage, frequency it is administered and the time of day the medication is administered. In addition, individual medications enter the infant's system differently through the gastrointestinal tract as well as breast milk and the impact of this on a newborn is not yet fully known.

Some doctors may stop taking stimulant medications during a woman's pregnancy due to the absence of research. This is a difficult decision for the patient, who must weigh the benefit of continuing her medication against the possible dangers to the embryo. Until more information becomes available, doctors may ask pregnant patients whether they have a history of ADHD or if they plan to take medication in the perinatal stage.

Many studies have shown that women can continue to take their ADHD medication safely while breastfeeding and during pregnancy. In response, a rising number of patients are choosing to do this. They have discovered, in consultation with their doctors, that the benefits of keeping their current medication outweigh any potential risks.

Women who suffer from ADHD who are planning to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss the medication they are taking with their physician, and the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also necessary to help pregnant women with adhd medication for adults uk recognize the signs and underlying disorder. They should also be educated about treatment options and strengthen strategies for coping. This should be a multidisciplinary process with the GPs, obstetricians and psychiatry. The pregnancy counselling should consist of the discussion of a plan for management for both the mother as well as the child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.

좋아요 0